scholarly journals Correlation Analysis between Traditional Chinese Medicine Syndromes and Gastrointestinal Bleeding after Percutaneous Coronary Intervention

2018 ◽  
Vol 2018 ◽  
pp. 1-10 ◽  
Author(s):  
Chenhao Zhang ◽  
Chaolian Huang ◽  
Mingming Wang ◽  
Xiaolin Kong ◽  
Guannan Liu ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Retrospective Study ◽  
Chinese Medicine ◽  
Blood Stasis ◽  
Coronary Intervention ◽  
Deficiency Syndrome ◽  
Blood Stasis Syndrome ◽  
Yin Deficiency ◽  
Percutaneous Coronary ◽  
Heart Blood

Objective. To explore the characters of traditional Chinese medicine (TCM) syndromes after percutaneous coronary intervention (PCI) and to provide syndrome study theoretical evidence for TCM differentiation treatment after PCI through retrospective study. Methods. Patients with coronary heart disease (CHD) who underwent PCI in Cardiovascular Intervention Center of Wangjing Hospital during Dec. 2012 to Dec. 2014 and met the inclusion criteria were enrolled. Retrospective study was then conducted based on patients’ clinical document and angiography data to explore the distribution pattern of TCM syndromes. Results. 801 patients were recruited in the study. TCM syndromes in descending order of their incidence were Qi deficiency and blood stasis syndrome, heart blood stasis syndrome, Qi and Yin deficiency syndrome, phlegm and blood stasis syndrome, Qi stagnation and blood stasis syndrome, Yang asthenia syndrome, heart and kidney yin deficiency syndrome to cold congeal, and blood stasis syndrome in a more to less order. Qi deficiency and blood stasis syndrome was in the most (occurring in 298 patients, 37.20%); Qi and Yin deficiency syndrome occurred in 163 patients (20.35%); heart blood stasis syndrome was shown in 126 patients (15.73%); phlegm and blood stasis syndrome was shown in 95 patients (11.86%). Conclusion. Qi deficiency and blood stasis syndrome was closely associated with post-PCI bleeding, implying that this syndrome might serve as a powerful predictor of GI bleeding as well as a potential supplement to the current predicting and scoring system of bleeding such as CRUSADE.

Safety of same-day–discharge radial percutaneous coronary intervention: a retrospective study

2003 ◽  
Vol 146 (4) ◽  
pp. 699-704 ◽  
Author(s):  
A.A Ziakas ◽  
B.P Klinke ◽  
C.R Mildenberger ◽  
D.E Fretz ◽  
E.M.B Williams ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Retrospective Study ◽  
Coronary Intervention ◽  
Percutaneous Coronary ◽  
Same Day Discharge

scholarly journals The Effects of Xuefu Zhuyu and Shengmai on the Evolution of Syndromes and Inflammatory Markers in Patients with Unstable Angina Pectoris after Percutaneous Coronary Intervention: A Randomised Controlled Clinical Trial

2013 ◽  
Vol 2013 ◽  
pp. 1-9 ◽  
Author(s):  
Jie Wang ◽  
Xiaochen Yang ◽  
Fuyong Chu ◽  
Jianxin Chen ◽  
Qingyong He ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Angina Pectoris ◽  
Unstable Angina ◽  
Inflammatory Markers ◽  
Blood Stasis ◽  
High Sensitivity ◽  
Coronary Intervention ◽  
Unstable Angina Pectoris ◽  
Controlled Clinical Trial ◽  
Percutaneous Coronary

We evaluated the effects of the Xuefu Zhuyu capsule (XFZY) and the Shengmai capsule (SM) on the evolution of syndromes and inflammatory markers in patients with unstable angina pectoris (UAP) after percutaneous coronary intervention (PCI). Ninety patients with UAP after PCI were randomly and equally assigned to three groups: the XFZY group, the SM group, and the placebo group, with 30 patients in each group. Six syndrome factors (including Qi deficiency, yin deficiency, yang deficiency, blood stasis, phlegm, and Qi stagnation) and 4 inflammatory markers (high-sensitivity C-reactive protein (Hs-CRP), endothelins-1 (ET-1), matrix metalloproteinases-9 (MMP-9), and homocysteine (Hcy)) were observed at week 0 and at the 1st, 4th and 12th weeks. In conclusion, the evolution of syndromes present in patients with UAP after PCI followed these trends (1) The deficiency syndromes gradually increased during a 12-week period, but the excess syndromes first gradually decreased and then mildly increased after PCI. (2) XFZY and SM can prevent excess syndromes from increasing in the later stages and prevent deficiency syndromes from increasing in all stages. (3) XFZY and SMcan reduce the levels of the inflammatory markers, especially in the later stages after PCI.

scholarly journals Timi Flow Between Streptokinase and Alteplase in Successful Fibrinolytic

2019 ◽  
Vol 2 (1) ◽  
Author(s):  
Dika Ashrinda ◽  
Refli Hasan ◽  
Cut Aryfa Andra ◽  
Zulfikri Muhtar ◽  
Harris Hasan
Keyword(s):  
Blood Flow ◽  
Percutaneous Coronary Intervention ◽  
Retrospective Study ◽  
Coronary Artery ◽  
Myocardial Function ◽  
Coronary Intervention ◽  
Fibrinolytic Therapy ◽  
Timi Flow ◽  
Percutaneous Coronary ◽  
Improve Blood Flow

STEMI with onset≤12 hours, necessary to take Primary Percutaneous Coronary Intervention (pPCI), but if there is no facility, another therapy is fibrinolytic, to improve blood flow in the coronary artery and myocardial function, thus reducing infarction expansion. This is a retrospective study in STEMI patients onset≤12 hours, had performed successful fibrinolytic with Streptokinase (SK) and Alteplase (tPA) from January 2015 to August 2017. TIMI flow was assessed by coronary angiography. There were 54 patients who had performed successful fibrinolytic therapy with SK and tPA; each group had 27 patients. In the SK group, there were nine patients (33.3%) with TIMI flow 2 and 18 patients (66.7%) with TIMI flow 3. While in the tPA group there were 11 patients (40.7%) with TIMI flow 2, 16 patients (59.3%) with TIMI flow 3, (p=0.573). There is no difference in TIMI flow between SK and tPA on STEMI patients after success fibrinolytic therapy.

Sign in / Sign up

Export Citation Format

Share Document